Bradford Teaching Hospitals NHS Foundation Trust runs Bradford Royal Infirmary and St Luke's Hospital, Bradford in Bradford, West Yorkshire, England. A new ultrasound suite was opened in December 2013 to reduce waiting time for patients needing scans.

During the past decade, Bradford Teaching Hospitals NHS Foundation Trust conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 7 clinical trials were completed, i.e. on average, 26.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bradford Teaching Hospitals NHS Foundation Trust" #1 sponsor was "Pfizer" with 4 trials, followed by "Lymphoma Trials Office" with 3 trials sponsored, "Gynesonics" with 2 trials sponsored, "Institute of Cancer Research, United Kingdom" with 2 trials sponsored and "Medical Research Council" with 2 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bradford Teaching Hospitals NHS Foundation Trust" #1 collaborator was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "National Institutes of Health (NIH)" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Bradford Teaching Hospitals NHS Foundation Trust" are "Breast Cancer" (3 trials), "Lymphoma" (3 trials), "Asthma" (2 trials), "Bladder Cancer" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Bradford Teaching Hospitals NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Bradford Teaching Hospitals NHS Foundation Trust" are "Drug" (22 trials), "Other" (10 trials), "Device" (8 trials), "Radiation" (5 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "Placebo" (3 trials), "chlorambucil" (3 trials), "doxorubicin hydrochloride" (3 trials) and "vincristine sulfate" (3 trials). Other intervention names were less common.

The vast majority of trials in "Bradford Teaching Hospitals NHS Foundation Trust" are 39 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Bradford Teaching Hospitals NHS Foundation Trust". undefined are not yet recruiting, 10 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Bradford Teaching Hospitals NHS Foundation Trust, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bradford Teaching Hospitals NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

Bradford Teaching Hospitals NHS Foundation Trust has several departments that took part in Clinical trials: "Bradford Royal Infirmary; Oncology Department" - 4 trials